Albiñana, V., Gallardo-Vara, E., Rojas-P, I. d., Recio-Poveda, L., Aguado, T., Canto-Cano, A., . . . Botella, L. M. (2020). Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel–Lindau disease.
Citación estilo ChicagoAlbiñana, Virginia, et al. Targeting β2-adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma From Von Hippel–Lindau Disease. 2020.
Cita MLAAlbiñana, Virginia, et al. Targeting β2-adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma From Von Hippel–Lindau Disease. 2020.
Precaución: Estas citas no son 100% exactas.